Expense Ratio (Annual)

Expense Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The expense ratio is calculated by taking the operating expenses and then dividing them by earned premium. Calculated as: (Total Operating Expenses - Underwriting Losses Total) / Net Premiums Earned

Royalty Pharma PLC (RPRX) Expense Ratio data is not available.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$2.38B
Net Income	$770.95M
Cost of Goods Sold	--
Gross Profit	$2.38B
Operating Expenses	$818.67M
Operating Income	$1.56B
Non-Operating Income/Expense	$-235.33M
Pre-Tax Income	$1.32B
Normalized Pre-Tax Income	$1.28B
Income after Taxes	$1.32B
Income from Continuous Operations	$1.32B
Consolidated Net Income/Loss	$1.32B
Normalized Income after Taxes	$1.28B
EBIT	$1.56B
EBITDA	$1.59B
Weighted-Average Shares Outstanding (Basic)	429.80M
Weighted-Average Shares Outstanding (Diluted)	564.46M
Earnings per Share (EPS) (Basic)	$1.79
Earnings per Share (EPS) (Diluted)	$1.78
Balance Sheet Financials
Current Assets	$1.53B
Property, Plant, and Equipment	$16.21B
Long-Term Assets	$18.09B
Total Assets	$19.62B
Current Liabilities	$636.21M
Long-Term Debt	$8.57B
Long-Term Liabilities	$9.27B
Total Liabilities	$9.91B
Common Equity	$9.71B
Tangible Shareholders Equity	$8.79B
Shareholders Equity	$9.71B
Common Shares Outstanding	988.63M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$2.49B
Cash Flow from Investing Activities	$-1.61B
Cash Flow from Financial Activities	$-1.19B
Beginning Cash	$929.03M
End Cash	$618.70M
Increase/Decrease in Cash	$-310.33M
Stock-Based Compensation	$289.89M
Common Stock Dividends Paid	$-900.63M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.40
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.47
Debt to Equity Ratio	0.92
Gross Margin	100.00%
Operating Margin	65.58%
EBIT Margin	65.58%
EBITDA Margin	66.94%
Pre-Tax Profit Margin	55.68%
Profit Margin	32.42%
Free Cash Flow	$2.49B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.12
Inventory Turnover	--
Receiveable Turnover	81.12
Days Sales in Receivables	4.50
Return on Equity	13.63%
Return on Tangible Equity	15.06%
Return on Assets	6.75%
Return on Investments	7.24%
Book Value Per Share	$9.83
Free Cash Flow per Share	$4.41
Operating Cash Flow per Share	$4.41

Data from Zacks Investment Research, Inc.